Clincosm LogoSign in Get a demo

AML

Showing NaN - NaN of 14
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Myeloid Leukemia, MDS, Myeloid Malignancies Trial in Boston (Decitabine, Filgrastim)

Not yet recruiting
  • Acute Myeloid Leukemia
  • +6 more
  • Boston, Massachusetts
  • +1 more
Mar 31, 2023

AML, Acute Myeloid Leukemia Trial in Boston (DREAMLAND, CERENA)

Not yet recruiting
  • AML
  • Acute Myeloid Leukemia
  • DREAMLAND
  • CERENA
  • Boston, Massachusetts
    Massachusetts General Hospital
Aug 12, 2022

Hematologic Malignancy, AML, ALL Trial in Australia, United States (Tagraxofusp, Fludarabine, Cytarabine)

Not yet recruiting
  • Hematologic Malignancy
  • +10 more
  • Los Angeles, California
  • +28 more
Jul 26, 2022

Acute Myelogenous Leukemia, AML Trial in Boston (DC AML Vaccine)

Active, not recruiting
  • Acute Myelogenous Leukemia
  • AML
  • DC AML Vaccine
  • Boston, Massachusetts
    Beth Israel Deaconess Medical Center
Jan 25, 2022

GVHD, AML, ALL Trial in Boston (FLUDARABINE, CYCLOPHOSPHAMIDE, TBI)

Recruiting
  • GVHD
  • +15 more
  • Boston, Massachusetts
    Massachusetts General Hospital
Sep 30, 2021

AML Trial in Worldwide (Quizartinib, Salvage Chemotherapy)

Completed
Has Results
  • AML
  • Duarte, California
  • +130 more
Feb 2, 2021

AML Trial in Boston (Etoposide, Cytarabine, Lenalidomide)

Active, not recruiting
Has Results
  • AML
  • Boston, Massachusetts
  • +2 more
Jan 13, 2021

AML, ALL, Undifferentiated Leukemia Trial in Boston (Abatacept)

Completed
Has Results
  • AML
  • +11 more
  • Boston, Massachusetts
    Boston Children's Hospital
Oct 31, 2019

AML Trial in Boston (Volasertib, Cytarabine, Idarubicin)

Withdrawn
  • AML
  • Boston, Massachusetts
  • +1 more
May 3, 2018

Advanced and Selected Solid Tumors, AML, High Risk and Very High Risk MDS Trial in Worldwide (BYL719, MEK162)

Completed
  • Advanced and Selected Solid Tumors
  • +2 more
  • La Jolla, California
  • +15 more
Sep 29, 2017

AML, ALL, CLL Trial in Boston (Cyclophosphamide; Fludarabine; Cyclosporin; CAMPATH-1H (Alemtuzumab); GM-CSF)

Completed
  • AML
  • +8 more
  • Cyclophosphamide; Fludarabine; Cyclosporin; CAMPATH-1H (Alemtuzumab); GM-CSF
  • Boston, Massachusetts
    Beth Israel Deaconess Medical Center
Jul 14, 2016

AML, CML, MDS Trial in Boston, New York, San Antonio (STA-9090 (ganetespib))

Completed
  • AML
  • +3 more
  • STA-9090 (ganetespib)
  • Boston, Massachusetts
  • +2 more
Sep 17, 2014

AML Trial in Canada, United States (Obatoclax)

Completed
  • AML
  • Chicago, Illinois
  • +12 more
Aug 16, 2013

Hematologic Malignancy, AML, ALL Trial in Boston (CD+8 T cell depletion)

Completed
  • Hematologic Malignancy
  • +6 more
  • CD+8 T cell depletion
  • Boston, Massachusetts
  • +1 more
Mar 15, 2012